The business provides contract manufacturing services for vaccines and therapies to biotechnology companies as well as large biopharma customers. Henogen has two locations in Seneffe and Gosselies, Belgium, with approximately 400 employees. The 2020 estimated revenues were 80 million euros ($95 million).

Henogen will become part of Thermo Fisher Scientific's Pharma Services business within its Laboratory Products and Services Segment.

Thermo Fisher subsidizes more sequencers for global coronavirus research
Thermo Fisher Scientific is expanding a global SARS-CoV-2 program that provides its next-generation sequencers at subsidized prices to help analyze new...

Thermo Fisher launches managed equipment plan
Thermo Fisher Scientific has launched a new subscription-based program called Managed Equipment Solutions that combines instrument and equipment sales...

Sartorius to acquire Novasep's chromatography division
Sartorius has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.

Thermo Fisher acquires Phitonex
Thermo Fisher Scientific has completed its acquisition of Phitonex, a North Carolina-based company that has created a spectral dye platform for high-resolution...

Sensorion, Novasep ink gene therapy agreement
Sensorion and Novasep have signed an agreement for the manufacturing of adeno-associated virus vectors covering a gene therapy program that targets OTOF,...

Novasep, Lysogene partner for gene therapy
Novasep and Lysogene announced that the parties have inked an agreement for the development and manufacturing of an adeno-associated viral vector-based...